| Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function KC Jambo, DH Banda, AM Kankwatira, N Sukumar, TJ Allain, ... Mucosal immunology 7 (5), 1116-1126, 2014 | 233 | 2014 |
| Mycobacterium and the coat of many lipids DG Russell, HC Mwandumba, EE Rhoades The Journal of cell biology 158 (3), 421-426, 2002 | 230 | 2002 |
| The macrophage marches on its phagosome: dynamic assays of phagosome function DG Russell, BC VanderVen, S Glennie, H Mwandumba, RS Heyderman Nature Reviews Immunology 9 (8), 594-600, 2009 | 228 | 2009 |
| Single-dose liposomal amphotericin B treatment for cryptococcal meningitis JN Jarvis, DS Lawrence, DB Meya, E Kagimu, J Kasibante, E Mpoza, ... New England Journal of Medicine 386 (12), 1109-1120, 2022 | 217 | 2022 |
| Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection HC Mwandumba, DG Russell, MH Nyirenda, J Anderson, SA White, ... The Journal of Immunology 172 (7), 4592-4598, 2004 | 186 | 2004 |
| High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi MG Chibwana, KC Jere, R Kamn’gona, J Mandolo, V Katunga-Phiri, ... medrxiv, 2020 | 137 | 2020 |
| Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state E Mitsi, R Kamng’ona, J Rylance, C Solórzano, J Jesus Reiné, ... Respiratory research 19, 1-4, 2018 | 128 | 2018 |
| Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung D Pisu, L Huang, V Narang, M Theriault, G Lę-Bury, B Lee, AE Lakudzala, ... Journal of Experimental Medicine 218 (9), e20210615, 2021 | 121 | 2021 |
| Pharmacodynamic modeling of bacillary elimination rates and detection of bacterial lipid bodies in sputum to predict and understand outcomes in treatment of pulmonary tuberculosis DJ Sloan, HC Mwandumba, NJ Garton, SH Khoo, AE Butterworth, ... Clinical infectious diseases 61 (1), 1-8, 2015 | 87 | 2015 |
| Pyogenic lung infections: factors for predicting clinical outcome of lung abscess and thoracic empyema HC Mwandumba, NJ Beeching Current opinion in pulmonary medicine 6 (3), 234-239, 2000 | 84 | 2000 |
| Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study A Gupta-Wright, K Fielding, JJ van Oosterhout, M Alufandika, DJ Grint, ... The Lancet HIV 7 (9), e620-e628, 2020 | 83 | 2020 |
| Etiology and risk factors for mortality in an adult community-acquired pneumonia cohort in Malawi SJ Aston, A Ho, H Jary, J Huwa, T Mitchell, S Ibitoye, S Greenwood, ... American journal of respiratory and critical care medicine 200 (3), 359-369, 2019 | 81 | 2019 |
| Asymptomatic HIV-infected Individuals on Antiretroviral Therapy Exhibit Impaired Lung CD4+ T-Cell Responses to Mycobacteria KC Jambo, DH Banda, L Afran, AM Kankwatira, RD Malamba, TJ Allain, ... American journal of respiratory and critical care medicine 190 (8), 938-947, 2014 | 62 | 2014 |
| Fully intermittent dosing with drugs for treating tuberculosis in adults HC Mwandumba, SB Squire, Cochrane Infectious Diseases Group Cochrane Database of Systematic Reviews 2019 (5), 1996 | 59 | 1996 |
| Inhibition of the lncRNA SAF drives activation of apoptotic effector caspases in HIV-1–infected human macrophages S Boliar, DW Gludish, KC Jambo, R Kamng’ona, L Mvaya, ... Proceedings of the National Academy of Sciences 116 (15), 7431-7438, 2019 | 58 | 2019 |
| Cryptococcal meningitis in Lilongwe and Blantyre, Malawi D Maher, H Mwandumba Journal of Infection 28 (1), 59-64, 1994 | 58 | 1994 |
| Cryptococcal meningoencephalitis: time for action KE Stott, A Loyse, JN Jarvis, M Alufandika, TS Harrison, HC Mwandumba, ... The Lancet Infectious Diseases 21 (9), e259-e271, 2021 | 50 | 2021 |
| AMBIsome Therapy Induction OptimisatioN (AMBITION): high dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a phase 3 … DS Lawrence, N Youssouf, SF Molloy, A Alanio, M Alufandika, ... Trials 19, 1-13, 2018 | 49 | 2018 |
| Genetic determinants of the pharmacokinetic variability of rifampin in Malawian adults with pulmonary tuberculosis DJ Sloan, AD McCallum, A Schipani, D Egan, HC Mwandumba, SA Ward, ... Antimicrobial Agents and Chemotherapy 61 (7), 10.1128/aac. 00210-17, 2017 | 48 | 2017 |
| The clinical impact of nucleic acid amplification tests on the diagnosis and management of tuberculosis in a British hospital M Taegtmeyer, NJ Beeching, J Scott, K Seddon, S Jamieson, SB Squire, ... Thorax 63 (4), 317-321, 2008 | 41 | 2008 |
